Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1977 Sep 1;146(3):735-46.
doi: 10.1084/jem.146.3.735.

Phytohemagglutinin-induced differentiation and blastogenesis of precursor T cells from mouse bone marrow

Phytohemagglutinin-induced differentiation and blastogenesis of precursor T cells from mouse bone marrow

O W Press et al. J Exp Med. .

Abstract

The cells in mouse bone marrow (BM) capable of responding to phytohemagglutinin (PHA) were shown to be precursor T cells in experiments employing athymic mice, immunofluorescence, and specific lysis of T or B cells with cytotoxic antisera + complement. In contrast, the responses of lymph node (LN) and spleen (Spl) cells to this mitogen were shown by the same techniques to rely upon resident populations of mature T lymphocytes in these peripheral lymphoid organs. Cytolysis of T cells with anti-theta (anti-Thy 1), anti-thymocyte, or anti-brain antisera abolished the PHA responses of LN and Spl, but had no appreciable effect on the BM PHA response. Lysis of B cells with anti-mouse gamma globulin or anti-mouse IgM antisera had no significant effect on either Spl or BM blastogenesis in response to this lectin. Immunofluorescent studies with fluoresceinated anti-brain sera demonstrated acquisition of T-cell surface antigens by BM null lymphocytes during the blastogenic response of this tissue to PHA. The results of these immunofluorescence experiments were reproducible even when marrow obtained from nude mice and pretreated with anti-brain serum plus complement was employed. The implications of these findings with regard to prophylaxis against graft versus host disease in BM transplant recipients are discussed.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Exp Hematol. 1976 Nov;4(6):354-64 - PubMed
    1. J Immunol. 1976 Nov;117(5 Pt 1):1656-63 - PubMed
    1. Cell Immunol. 1977 Jan;28(1):218-28 - PubMed
    1. Cell Immunol. 1977 Jan;28(1):206-17 - PubMed
    1. Cell Immunol. 1972 Sep;5(1):74-86 - PubMed

Publication types